Skip to main content

Table 4 Characteristics of homeless persons with AIDS who did and did not receive health department supportive housing, in San Francisco, 1996–2006 (N = 676)*

From: Impact of housing on the survival of persons with AIDS

Characteristics Received Supportive Housing
  Yes No  
  (N = 70) (N = 606)  
  N % N % P value
Gender      0.1448
   Male 48 68.57 472 77.89  
   Female 16 22.86 86 14.19  
   Transgender 6 8.57 48 7.92  
Age at diagnosis (years)      0.0637
   13–29 8 11.43 82 13.53  
   30–39 22 31.43 244 40.26  
   40–49 25 35.71 214 35.31  
   50+ 15 21.43 66 10.89  
Race/ethnicity      0.5319
   White 27 38.57 248 40.92  
   African American 28 40.00 237 39.11  
   Latino 10 14.29 99 16.34  
   Asian/Pacific Islander/Native American/Other 5 7.14 22 3.63  
Risk group      0.2825
   Men who have sex with men 19 27.14 123 20.30  
   Injection drug user 31 44.29 241 39.77  
   Men who have sex with men and inject drugs 17 24.29 207 34.16  
   Heterosexual/Other 3 4.29 35 5.78  
Insurance status      0.0695
   Public 26 37.14 205 33.83  
   Private 3 4.29 5 0.83  
   None 40 57.14 383 63.20  
   Unknown 1 1.43 13 2.15  
Initial AIDS diagnosis      0.9964
   CD4 count <200 cells/mm3 55 78.57 476 78.55  
   Opportunistic illness 15 21.43 130 21.45  
CD4 count at diagnosis (mean cells/mm 3 )   176   172 0.8368
Ever received highly active antiretroviral therapy      0.1052
   Yes 56 80.00 429 70.79  
   No 14 20.00 177 29.21  
Ever received prophylaxis against Pneumocystis jirovecii pneumonia      0.7236
   Yes 47 67.14 394 65.02  
   No 23 32.86 212 34.98  
Ever received prophylaxis against Mycobacterium avium complex      0.9886
   Yes 19 27.14 164 27.06  
   No 51 72.86 442 72.94  
  1. * Includes 35 additional cases not originally recorded as homeless at diagnosis but who matched with the housing database and had a move-in date that was later than the AIDS diagnosis date.
  2. †Chi square test for differences in proportions and t test for differences in means.
  3. ‡Excludes 23 cases that were missing CD4 results.